Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01273961 · ClinicalTrials.gov registry record · NA
Study of Radiofrequency Device for Use in Non-Invasive Cosmetic Procedures
A NA study, sponsored by Rocky Mountain Biosystems.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01273961 is a NA study that has completed, run by Rocky Mountain Biosystems. The registered enrollment target is 20 participants.
The verdict
NCT01273961, a NA study, has completed, sponsored by Rocky Mountain Biosystems.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this pilot research study is to collect information on the safety and effectiveness of an experimental device used to treat and improve the appearance of the skin by reducing the visibility of wrinkles and by reducing the looseness of skin.
Interventions
- DEVICE AuraLevée treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-12 |
| Est. Completion | 2012-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01273961
The ClinicalTrials.gov registry entry for NCT01273961 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rocky Mountain Biosystems, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AuraLevée treatment is the first listed.
NCT01273961 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01273961 about?
NCT01273961 is a clinical study titled "Study of Radiofrequency Device for Use in Non-Invasive Cosmetic Procedures". The purpose of this pilot research study is to collect information on the safety and effectiveness of an experimental device used to treat and improve the appearance of the skin by reducing the visibility of wrinkles and by reducing the looseness of skin.
What is the current status of trial NCT01273961?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2010-12. Estimated completion is 2012-01.
What interventions are being tested in trial NCT01273961?
The interventions under investigation include: AuraLevée treatment (DEVICE).
Who is sponsoring clinical trial NCT01273961?
This trial is sponsored by Rocky Mountain Biosystems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.